Oil & Gas blocks: Vedanta wins 10, ONGC bags 8
Oil & Gas blocks: Vedanta wins 10, ONGC bags 8

Oil & Gas blocks: Vedanta wins 10, ONGC bags 8

DSIJ Intelligence Article rating: 3.0

In the latest government auction, Vedanta has won 10 oil and gas (O&G) exploration blocks and ONGC has won 8. Reacting to the development, the shares of ONGC gained, while Vedanta slid.

Zydus Cadila gets USFDA approval for Misoprostol Tablets
Zydus Cadila gets USFDA approval for Misoprostol Tablets

Zydus Cadila gets USFDA approval for Misoprostol Tablets

Apurva Joshi Article rating: 3.8

USFDA has given the final approval to Zydus Cadila to market Misoprostol Tablets, 100 mcg and 200 mcg. The drug will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad.

Asian Granito bags orders worth Rs 175 crore
Asian Granito bags orders worth Rs 175 crore

Asian Granito bags orders worth Rs 175 crore

DSIJ Intelligence Article rating: 4.0

Asian Granito India Ltd (AGIL) received a hearty response from the dealer meet organised during June 16 to July 2, 2019. The company has landed orders to the tune of Rs. 175 crore.

Dr. Reddys launches Carboprost Tromethamine Injection USP
Dr. Reddys launches Carboprost Tromethamine Injection USP

Dr. Reddys launches Carboprost Tromethamine Injection USP

Apurva Joshi Article rating: 5.0

Dr. Reddy’s Laboratories Limited has announced the launch of Carboprost Tromethamine Injection USP, 250 mcg/mL (1mL) Single-dose Vial, a therapeutic equivalent generic version of Hemabate injection, 250 mcg/mL, approved by the US Food and Drug Administration (USFDA).

USFDA completes inspection of JBCPL without observations
USFDA completes inspection of JBCPL without observations

USFDA completes inspection of JBCPL without observations

Apurva Joshi Article rating: 2.9

The USFDA has successfully completed the inspection of JB Chemicals & Pharmaceuticals Limited's (JBCPL) newly set up and commissioned solid oral dosage formulation manufacturing facility at Panoli, Gujarat.

RSS
First32793280328132823284328632873288Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR